Is 6-Shogaol an Effective Phytochemical for Patients With Lower-risk Myelodysplastic Syndrome? A Narrative Review

Is 6-Shogaol an Effective Phytochemical for Patients With Lower-risk Myelodysplastic Syndrome? A Narrative Review

Myelodysplastic syndrome (MDS) evolves due to genomic instability, dysregulated signaling pathways, and overproduction of inflammatory markers. Reactive oxygen species contribute to the inflammatory response, which causes gene damage, cellular remodeling, and fibrosis. MDS can be a debilitating cond...

Full description

Bibliographic Details
Main Authors: Soo Liang Ooi PhD candidate, Ron Campbell BMedSc(Hons), FRACGP, Sok Cheon Pak PhD, Terry Golombick PhD, Arumugam Manoharan MD, FRACP, FRCPA, Raj Ramakrishna MD, FRACP, FRCPA, Vladimir Badmaev MD, PhD, Janet Schloss PhD
Format: Article
Language:English
Published: SAGE Publishing 2021-12-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/15347354211065038

Internet

https://doi.org/10.1177/15347354211065038

Similar Items